Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
AnaptysBio(ANAB) Newsfilter·2024-05-10 04:10AnaptysBio(ANAB) Newsfilter·2024-05-10 04:10
R1AnaptysBio(ANAB) Newsfilter·2024-05-10 04:10